anmelden
FTSE All-Share
5.738,51
PKT
+16,98
PKT
+0,30
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.03.20 | Barclays Sector Perform | RBC Capital Markets | |
| 17.03.20 | HSBC Underperform | RBC Capital Markets | |
| 17.03.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 17.03.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 17.03.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 16.03.20 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 16.03.20 | Shell (ex Royal Dutch Shell) Hold | Jefferies & Company Inc. | |
| 16.03.20 | BP Hold | Jefferies & Company Inc. | |
| 16.03.20 | BP Underperform | RBC Capital Markets | |
| 16.03.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 16.03.20 | Diageo buy | Goldman Sachs Group Inc. | |
| 13.03.20 | National Grid buy | Deutsche Bank AG | |
| 12.03.20 | Prudential overweight | Morgan Stanley | |
| 12.03.20 | BP Neutral | Credit Suisse Group | |
| 12.03.20 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 12.03.20 | BP buy | HSBC | |
| 12.03.20 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 12.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.03.20 | BP overweight | JP Morgan Chase & Co. | |
| 12.03.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 12.03.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 12.03.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 12.03.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 11.03.20 | Prudential buy | Goldman Sachs Group Inc. | |
| 11.03.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 11.03.20 | London Stock Exchange (LSE) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.20 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 11.03.20 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.03.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 10.03.20 | Unilever kaufen | Credit Suisse Group | |
| 10.03.20 | Unilever kaufen | Credit Suisse Group | |
| 10.03.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 10.03.20 | Prudential buy | UBS AG | |
| 10.03.20 | Vodafone Group buy | UBS AG | |
| 10.03.20 | BAT Outperform | Credit Suisse Group | |
| 10.03.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 10.03.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.03.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 10.03.20 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 09.03.20 | AstraZeneca Sell | UBS AG |